Brace Eze
Register   Login 
 
 News   
Search News
 
 
 
News Categories
 
 
 
Latest Dental News
 
 
 
Survey
 
Does the ADA represent you?


Submit Survey  View Results
 
 
Latest Breaking News
 
 
 
 
 
Trident® and Smiles Across America® Team Up to Help Promote Healthy Mouths for Denver Children
 
  Tooth decay is the most common chronic childhood disease in America(1), yet over eight in ten (84%) American parents don't realize this(2).  Smiles Across America ® (SAA), an Oral Health America program led in conjunction with Trident ® gum, is pleased to welcome Denver -based Kids in Need of De...
 
Full Story
 
 
 
Curemark Opens Autism Trials at New Jersey Site
 
  Curemark, LLC, a drug research and development company focused on the treatment of neurological diseases, announced that Saint Peter's University Hospital in New Brunswick, New Jersey, is participating in the company's Phase III clinical trials for CM-AT, Curemark's autism treatment. 
 
Full Story
 
 
 
My Kid's Dentist Announces the Grand Opening of its Newest Office in Valencia, CA
 
  My Kid's Dentist, a leading provider in pediatric dentistry, is excited to announce the Grand Opening of its latest office in Valencia, CA.  The office is located at 28134 Newhall Ranch Road on the corner of Copper Hill & Newhall Ranch, in the Highridge Crossing Shopping Center, near Office Depot a...
 
Full Story
 
 
rss
Researchers Find New Translocation; Weak Spots in DNA Cause Genetic Disease
News on Thursday, July 29, 2010 9:39 AM

A genetics research team based at The Children's Hospital of Philadelphia continues to discover recurrent translocations—places in which two chromosomes exchange pieces of themselves.

Read More
 
Birner Dental Management Services, Inc. Schedules Earnings Call to Discuss Second Quarter 2010 Results
News on Thursday, July 29, 2010 9:22 AM

Birner Dental Management Services, Inc., operators of PERFECT TEETH dental practices, will conduct a conference call to review second quarter 2010 results.  In addition to second quarter results, the...

Read More
 
Shionogi Inc. Announces FDA Approval of CUVPOSA™ for the Treatment of Chronic Severe Drooling in Pediatric Patients With Neurologic Conditions
News on Thursday, July 29, 2010 9:20 AM

Shionogi Inc., a U.S.-based group company of Shionogi & Co., Ltd., today announced the U.S. Food and Drug Administration approval of CUVPOSA™ (glycopyrrolate), the first liquid treatment for patients...

Read More
 
Survey: 30 percent on Gulf Coast Suffer From Mental Illness in Wake of Oil Spill
News on Thursday, July 29, 2010 9:20 AM

The oil spill ravaging the Gulf of Mexico has inflicted widespread psychological distress among coastal residents of Louisiana, Mississippi, Alabama and Florida, etching scars even deeper than those ...

Read More
 
Sales of Drugs From Multinational Corporations Will Represent 92 Percent of Mexico's Non-Small-Cell Lung Cancer Drug Market in 2014
News on Thursday, July 29, 2010 9:16 AM

Decision Resources, one of the world's leading research and advisory firms focusing on pharmaceutical and healthcare issues, finds that in 2014, sales of drugs from multinational corporations will re...

Read More
 
Trident® and Smiles Across America® Team Up to Help Promote Healthy Mouths for Denver Children
News on Wednesday, July 28, 2010 10:18 PM

Tooth decay is the most common chronic childhood disease in America(1), yet over eight in ten (84%) American parents don't realize this(2).  Smiles Across America ® (SAA), an Oral Health America pro...

Read More
 
New Advances in Understanding of Parasite Risk Showcased at CVBD World Forum
News on Wednesday, July 28, 2010 10:01 AM

Fascinating studies giving new insights into the spread of leishmaniosis in the UK and France , the appearance of new CVBDs in Germany , the state of heartworm infection in Korea and the neurologic...

Read More
 
Texas Health Plano, Texas Back Institute Offer SpineAssist® Surgical Robot for Spine Surgeries
News on Wednesday, July 28, 2010 9:59 AM

The SpineAssist® surgical robot – one of three in the United States and the only one in Texas – is the only surgical robot designed specifically to operate on the spine. Accurate to less than hal...

Read More
 
Teva Respiratory Announces Positive Results From Phase III Trial of BDP HFA Nasal Aerosol in Seasonal Allergic Rhinitis
News on Wednesday, July 28, 2010 9:56 AM

Teva Respiratory today announced positive results from a Phase III trial evaluating the efficacy and safety of beclomethasone dipropionate (BDP) hydrofluoroalkane (HFA) Nasal Aerosol in the treatment...

Read More
 
Boston Scientific Launches Neuroform EZ(TM) Stent System in U.S. and Europe
News on Wednesday, July 28, 2010 9:25 AM

Boston Scientific Corporation today announced the U.S. and European launches of the Neuroform EZ(TM) Stent System, its fourth-generation intracranial aneurysm stent system designed for use in conjunc...

Read More
 
Curemark Opens Autism Trials at New Jersey Site
News on Wednesday, July 28, 2010 9:20 AM

Curemark, LLC, a drug research and development company focused on the treatment of neurological diseases, announced that Saint Peter's University Hospital in New Brunswick, New Jersey, is participati...

Read More
 
Promise for Herpes, Staph Sufferers Shown in Probiotic-Derived Immune Support Supplement
News on Tuesday, July 27, 2010 9:29 AM

Dr. Lubov Shynkarenko , vice president and lead researcher of Pure Research Products, LLC, recently presented findings that demonstrate the company's probiotic-derived supplement's potential to supp...

Read More
 
Page:   of 215 
     
 

Dental News Dentistry News Dental Hygiene News Health Industry News
Health News FDA News Dental Industry News Dental Products News

Genetic Markers Identified for Alcohol Response in UCSF Gallo Study

Researchers at the UCSF Ernest Gallo Clinic and Research Center have identified a region on the human genome that appears to determine how strongly drinkers feel the effects of alcohol and thus how prone they are to alcohol abuse.

(Vocus/PRWEB ) December 9, 2008 -- Researchers at the UCSF Ernest Gallo Clinic and Research Center have identified a region on the human genome that appears to determine how strongly drinkers feel the effects of alcohol and thus how prone they are to alcohol abuse.

The researchers found that a DNA sequence variation, known as a single nucleotide polymorphism (SNP), on chromosome 15 is significantly associated with the level of response to alcohol and could signal the genetic factors that affect alcohol abuse, according to findings published in the Dec. 8 online edition of the "Proceedings of the National Academy of Sciences."

The research investigated two sentinel SNP markers - RS1051730 and RS8034191 -that previously had been associated with nicotine dependence and lung cancer and found a strong association with the first marker, according to Raymond L. White, PhD, director of the Gallo Center and senior author on the paper.

"We know that the level of response to alcohol is heritable and think there are genetic factors behind 40 to 60 percent of alcohol dependence, but until now, the chromosomal locations of these factors have not been clear for the most common forms of alcohol use disorders," White said. "By understanding which portion of our genetic makeup influences our response to alcohol, we can begin to understand what type of treatments might be most successful in helping reduce alcohol use disorders."

Previous studies have indicated shared genetic factors behind alcohol and nicotine dependence and also have connected chromosome 15 with alcohol use disorders, which made those sites a logical place to start searching for a genetic basis for alcohol response, White said.

The research determined the genetic makeup, or genotype, of 313 Caucasian siblings from the San Diego Sibling Pair Project and analyzed the association of the two sentinel SNPs associated with nicotine dependence, with three measures of the level of response. A low level of response reflects an ability to consume greater amounts of alcohol before feeling the effects. Additional genotyping for verification and expansion of the study resulted in a total of 367 genotyped white siblings. The findings confirmed that the level of response to alcohol has a genetic component, according to the paper.

This level of response to alcohol intake - including physical responses such as body swaying and subjective feelings as measured on the Subjective High Assessment Scale - serves as an "intermediate phenotype" that is highly reproducible in individuals and can be a means of investigating the genetic factors that affect alcohol abuse, the researchers said.

"In many complex psychiatric and medical conditions, such as substance abuse, there are multiple genetic and environmental components involved, making it very difficult to firmly identify the genetic component," White said. "In those situations, intermediate phenotypes are often more closely correlated with the underlying biology than any other factor and are invaluable research aids."

The most significant association in this study was found on the chromosome 15 SNP labeled RS1051730, with the response being body sway resulting from a 3-drink challenge at 10:00 am, researchers said.

Several other genes surrounding this marker could be responsible for the variation in level of response. However, the authors did say that they suspect that the nicotinic receptor gene CHRNA5 may be responsible.

Co-authors on the paper were Geoff Joslyn, Gerry Brush and Margaret Robertson, from the Gallo Center; and Tom L. Smith, Jelger Kalmijn and Marc Schuckit, from the University of California San Diego Department of Psychiatry and the Veterans Affairs San Diego Healthcare System.

Support for the research came from funds provided by the State of California for UCSF medical research on alcohol and substance abuse. It was also sponsored by the Department of the Army, through the US Army Medical Research Acquisition Activity office. The research does not necessarily reflect the position or the policy of the government, nor should any official endorsement of the research be inferred.

The Ernest Gallo Clinic and Research Center at UCSF is one of world's preeminent academic centers for the study of the biological basis of alcohol and substance abuse. It is the only center studying alcoholism in the United States that is based in a department of neurology. Gallo Center discoveries of potential molecular targets for the development of therapeutic medications are extended through preclinical and proof-of-concept clinical studies.

UCSF is a leading university dedicated to promoting health worldwide through advanced biomedical research, graduate-level education in the life sciences and health professions, and excellence in patient care. For further information, visit www.ucsf.edu.

The article is available at http://www.pnas.org/cgi/doi/10.1073/pnas.0810970105

Corinna Kaarlela, News Director
Source: Kristen Bole (415) 476-2557
Web:
www.ucsf.edu


Posted on Tuesday, December 09, 2008 (Archive on Tuesday, January 06, 2009)
Posted by News  Contributed by
Return    

Rating:
Comments:
Save

Current Rating:
 
 

News

 
 
 

Get Adobe Flash player Install latest flash player if you can't see this gallery.

 
 
 
 
 
 
Weather
 
Lookup
Chino, CA
63°F
Feels like 63°F
Fair Night
10:53 PM PDT

UV Index: 0 - Low
Dew Point: 54°F
Humidity: 72%
Visibility: 10.0 mi
Pressure: 29.98 in and steady
Daylight: 6:00 AM - 7:53 PM
Wind: Calm

Get Extended Forecast!

 
 
News Archive
 
 
 
 
 Copyright (c) 2010 UDENT!   Terms Of Use  Privacy Statement